7T6F image
Entry Detail
PDB ID:
7T6F
EMDB ID:
Title:
Structure of active Janus Kinase (JAK) dimer complexed with cytokine receptor intracellular domain
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2021-12-13
Release Date:
2022-03-16
Method Details:
Experimental Method:
Resolution:
3.60 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Tyrosine-protein kinase
Mutations:V657F
Chain IDs:A, D (auth: B)
Chain Length:1173
Number of Molecules:2
Biological Source:Mus musculus
Polymer Type:polypeptide(L)
Description:Interferon lambda receptor 1
Chain IDs:B (auth: C), C (auth: D)
Chain Length:85
Number of Molecules:2
Biological Source:Mus musculus
Primary Citation
Structure of a Janus kinase cytokine receptor complex reveals the basis for dimeric activation.
Science 376 163 169 (2022)
PMID: 35271300 DOI: 10.1126/science.abn8933

Abstact

Cytokines signal through cell surface receptor dimers to initiate activation of intracellular Janus kinases (JAKs). We report the 3.6-angstrom-resolution cryo-electron microscopy structure of full-length JAK1 complexed with a cytokine receptor intracellular domain Box1 and Box2 regions captured as an activated homodimer bearing the valine→phenylalanine (VF) mutation prevalent in myeloproliferative neoplasms. The seven domains of JAK1 form an extended structural unit, the dimerization of which is mediated by close-packing of the pseudokinase (PK) domains from the monomeric subunits. The oncogenic VF mutation lies within the core of the JAK1 PK interdimer interface, enhancing packing complementarity to facilitate ligand-independent activation. The carboxy-terminal tyrosine kinase domains are poised for transactivation and to phosphorylate the receptor STAT (signal transducer and activator of transcription)-recruiting motifs projecting from the overhanging FERM (four-point-one, ezrin, radixin, moesin)-SH2 (Src homology 2)-domains. Mapping of constitutively active JAK mutants supports a two-step allosteric activation mechanism and reveals opportunities for selective therapeutic targeting of oncogenic JAK signaling.

Legend

Protein

Chemical

Disease

Primary Citation of related structures